Huangma Technology(SH:603181) Orient Securities·2025-08-25 10:15Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company has demonstrated resilient growth in the second quarter, with a notable increase in sales volume and net profit despite a slight decline in sales prices. The company achieved a revenue of 1.194 billion yuan, representing a year-on-year growth of 7.67%, and a net profit attributable to the parent company of 219 million yuan, up 14.67% year-on-year [10] - The company is expected to benefit from a gradual stabilization of tariff policies and macroeconomic improvements, which may lead to a recovery in sales and performance growth in the second half of the year [10] - The company’s long-term growth potential is anticipated to accelerate due to the exit of traditional chemical production capacities in developed countries, creating opportunities for Chinese fine chemical companies like the company [10] Financial Performance Summary - Revenue (million yuan): 1,894 in 2023, projected to grow to 2,333 in 2024 (23.2% YoY), 2,659 in 2025 (14.0% YoY), 3,191 in 2026 (20.0% YoY), and 3,829 in 2027 (20.0% YoY) [8] - Operating profit (million yuan): 367 in 2023, projected to grow to 456 in 2024 (24.0% YoY), 520 in 2025 (14.2% YoY), 618 in 2026 (18.7% YoY), and 740 in 2027 (19.9% YoY) [8] - Net profit attributable to the parent company (million yuan): 325 in 2023, projected to grow to 398 in 2024 (22.5% YoY), 454 in 2025 (14.2% YoY), 539 in 2026 (18.7% YoY), and 647 in 2027 (19.9% YoY) [8] - Earnings per share (EPS): 0.55 in 2023, projected to increase to 0.68 in 2024, 0.77 in 2025, 0.92 in 2026, and 1.10 in 2027 [8] - Gross margin is expected to improve slightly from 24.6% in 2023 to 25.6% in 2025-2027 [8] Valuation and Price Target - The target price is set at 19.40 yuan, based on a 25 times price-to-earnings ratio, reflecting a 20% premium over comparable companies [6]